United States Biotechnology & Medical Research

Quoin Pharmaceuticals Ltd (QNRX)

Track

Ticker: QNRX Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Quoin Pharmaceuticals Ltd. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
2.5
LANGER DENNIS Non-Executive Director
Transaction date
Purchase
Price
38.76
Quantity 79,803 -16.1%
Value US$684,437
1.6
Carter Denise P. Chief Operating Officer Executive Director
Transaction date
Purchase
Price
227.87
Quantity 40,671 +43.1%
Value US$1,210,019
1.8
Myers Michael Chief Executive Officer Executive Director
Transaction date
Purchase
Price
394.45
Quantity 9,673 +43.0%
Value US$4,456,064
1.2
Dunn Gordon Chief Financial Officer Officer
Transaction date
Purchase
Price
0.45
Quantity 122,221 +423.6%
Value US$54,999
Culverwell Anthony James Non-Executive Director
Transaction date
Purchase
Price
0.45
Quantity 100,000 +31545.7%
Value US$45,000
1.2
Dunn Gordon Chief Financial Officer Officer
Transaction date
Purchase
Price
0.71
Quantity 10,000 +53.0%
Value US$7,100
1.2
Dunn Gordon Chief Financial Officer Officer
Transaction date
Purchase
Price
0.91
Quantity 10,000 +112.9%
Value US$9,100
1.2
Dunn Gordon Chief Financial Officer Officer
Transaction date
Purchase
Price
0.80
Quantity 4,000 +82.4%
Value US$3,200
1.2
Dunn Gordon Chief Financial Officer Officer
Transaction date
Purchase
Price
0.78
Quantity 4,000 +467.3%
Value US$3,120
1.2
Dunn Gordon Chief Financial Officer Officer
Transaction date
Purchase
Price
0.80
Quantity 856 +inf%
Value US$685
1.8
Myers Michael Chief Executive Officer Executive Director
Transaction date
Purchase
Price
0.80
Quantity 23,572 +99.5%
Value US$18,796
1.8
Myers Michael Chief Executive Officer Executive Director
Transaction date
Purchase
Price
0.75
Quantity 8,200 +53.0%
Value US$6,134
1.8
Myers Michael Chief Executive Officer Executive Director
Transaction date
Purchase
Price
0.66
Quantity 5,322 +52.4%
Value US$3,490
1.6
Carter Denise P. Chief Operating Officer Executive Director
Transaction date
Purchase
Price
0.80
Quantity 22,988 +95.4%
Value US$18,310
1.6
Carter Denise P. Chief Operating Officer Executive Director
Transaction date
Purchase
Price
0.75
Quantity 8,825 +57.8%
Value US$6,602
1.8
Myers Michael Chief Executive Officer Executive Director
Transaction date
Purchase
Price
0.62
Quantity 800 +8.5%
Value US$495
1.6
Carter Denise P. Chief Operating Officer Executive Director
Transaction date
Purchase
Price
0.66
Quantity 4,100 +36.7%
Value US$2,686
1.6
Carter Denise P. Chief Operating Officer Executive Director
Transaction date
Purchase
Price
0.63
Quantity 1,822 +19.5%
Value US$1,139
2.5
LANGER DENNIS Non-Executive Director
Transaction date
Sale
Price
0.73
Quantity 297 -84.9%
Value US$217
2.5
LANGER DENNIS Director Non-Executive Director
Transaction date
Proposed sale
Price
0.73
Quantity 297
Value US$218
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2025-10-15 2025-10-14 B Purchase
2.5
LANGER DENNIS
Non-Executive Director
79,803 -16.1%
38.76
US$684,437 		79,803 -16.1% 38.76 US$684,437
2024-12-27 2024-12-23 B Purchase
1.6
Carter Denise P.

Chief Operating Officer

Executive Director
40,671 +43.1%
227.87
US$1,210,019 		40,671 +43.1% 227.87 US$1,210,019
2024-12-27 2024-12-23 B Purchase
1.8
Myers Michael

Chief Executive Officer

Executive Director
9,673 +43.0%
394.45
US$4,456,064 		9,673 +43.0% 394.45 US$4,456,064
2024-12-27 2024-12-23 B Purchase
1.2
Dunn Gordon

Chief Financial Officer

Officer
122,221 +423.6%
0.45
US$54,999 		122,221 +423.6% 0.45 US$54,999
2024-12-27 2024-12-23 B Purchase
Culverwell Anthony James
Non-Executive Director
100,000 +31545.7%
0.45
US$45,000 		100,000 +31545.7% 0.45 US$45,000
2024-09-11 2024-09-10 B Purchase
1.2
Dunn Gordon

Chief Financial Officer

Officer
10,000 +53.0%
0.71
US$7,100 		10,000 +53.0% 0.71 US$7,100
2024-09-11 2024-09-10 B Purchase
1.2
Dunn Gordon

Chief Financial Officer

Officer
10,000 +112.9%
0.91
US$9,100 		10,000 +112.9% 0.91 US$9,100
2024-09-11 2024-09-09 B Purchase
1.2
Dunn Gordon

Chief Financial Officer

Officer
4,000 +82.4%
0.80
US$3,200 		4,000 +82.4% 0.80 US$3,200
2024-09-11 2024-09-09 B Purchase
1.2
Dunn Gordon

Chief Financial Officer

Officer
4,000 +467.3%
0.78
US$3,120 		4,000 +467.3% 0.78 US$3,120
2024-09-11 2024-09-09 B Purchase
1.2
Dunn Gordon

Chief Financial Officer

Officer
856 +inf%
0.80
US$685 		856 +inf% 0.80 US$685
2024-09-05 2024-09-04 B Purchase
1.8
Myers Michael

Chief Executive Officer

Executive Director
23,572 +99.5%
0.80
US$18,796 		23,572 +99.5% 0.80 US$18,796
2024-09-05 2024-09-04 B Purchase
1.8
Myers Michael

Chief Executive Officer

Executive Director
8,200 +53.0%
0.75
US$6,134 		8,200 +53.0% 0.75 US$6,134
2024-09-05 2024-09-04 B Purchase
1.8
Myers Michael

Chief Executive Officer

Executive Director
5,322 +52.4%
0.66
US$3,490 		5,322 +52.4% 0.66 US$3,490
2024-09-05 2024-09-04 B Purchase
1.6
Carter Denise P.

Chief Operating Officer

Executive Director
22,988 +95.4%
0.80
US$18,310 		22,988 +95.4% 0.80 US$18,310
2024-09-05 2024-09-04 B Purchase
1.6
Carter Denise P.

Chief Operating Officer

Executive Director
8,825 +57.8%
0.75
US$6,602 		8,825 +57.8% 0.75 US$6,602
2024-09-05 2024-09-03 B Purchase
1.8
Myers Michael

Chief Executive Officer

Executive Director
800 +8.5%
0.62
US$495 		800 +8.5% 0.62 US$495
2024-09-05 2024-09-03 B Purchase
1.6
Carter Denise P.

Chief Operating Officer

Executive Director
4,100 +36.7%
0.66
US$2,686 		4,100 +36.7% 0.66 US$2,686
2024-09-05 2024-09-03 B Purchase
1.6
Carter Denise P.

Chief Operating Officer

Executive Director
1,822 +19.5%
0.63
US$1,139 		1,822 +19.5% 0.63 US$1,139
2024-06-10 2024-06-07 S Sale
2.5
LANGER DENNIS
Non-Executive Director
297 -84.9%
0.73
US$217 		297 -84.9% 0.73 US$217
2024-06-07 2024-06-07 PrS Proposed sale
2.5
LANGER DENNIS

Director

Non-Executive Director
297
0.73
US$218 		297 0.73 US$218
Explore more

More insider trading research around Quoin Pharmaceuticals Ltd

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America